Insight Molecular Diagnostics Inc. Deferred Tax Assets, Equity Method Investments
Insight Molecular Diagnostics Inc. (IMDX) had Deferred Tax Assets, Equity Method Investments of $364.00 thousand as of 2022-12-31, per its 10-K filed 2024-04-16.
Discontinued › Notes › Components of Deferred Tax Assets and Liabilities › Deferred Tax Assets, Gross
us-gaap:DeferredTaxAssetsEquityMethodInvestments · last filed 2024-04-16
- 2022-12-31: Deferred Tax Assets, Equity Method Investments $364.00K.
- 2021-12-31: Deferred Tax Assets, Equity Method Investments $193.00K.
- 2020-12-31: Deferred Tax Assets, Equity Method Investments $193.00K; Deferred Tax Assets, Equity Method Investments as first filed $261.00K.
- 2019-12-31: Deferred Tax Assets, Equity Method Investments $261.00K; Deferred Tax Assets, Equity Method Investments as first filed $394.00K.
| Period end | Deferred Tax Assets, Equity Method Investments | Deferred Tax Assets, Equity Method Investments as first filed |
|---|---|---|
| 2022-12-31 | $364.00K 10-K · filed 2024-04-16 | |
| 2021-12-31 | $193.00K 10-K · filed 2023-04-12 | |
| 2020-12-31 | $193.00K 10-K · filed 2022-03-11 | $261.00K 10-K · filed 2021-03-19 |
| 2019-12-31 | $261.00K 10-K · filed 2022-03-11 | $394.00K 10-K · filed 2020-03-26 |
| 2018-12-31 | $393.00K 10-K · filed 2020-03-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |